Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | N/A | NA4452 | IM / RA |
| FLU3 | INFLUENZA (SEASONAL) (FLUCELVAX) | SEQIRUS, INC. | 1 | 407243 | IM / RA |
The patient received both the influenza vaccine and the Pfizer COVID-19 vaccine on October 1, 2025, at a community vaccine clinic held at the (withheld) Housing Authority, where she currently resides. At the patient?s request, both vaccines were administered in the same (right) arm. In the evening following vaccination, the patient reported tingling sensations in the head and down both arms, accompanied by an upset stomach. Due to these symptoms, she was transported to the emergency department for evaluation. The patient was hospitalized for three days for observation. During hospitalization, her care team explained that her symptoms may have been due to her body?s reaction to receiving both vaccines simultaneously. The patient was discharged in stable condition and has since returned home.
none
High cholesterol; diabetes Type 2
Folic acid 1 mg - 1 tab once daily; Citalopram 20 mg - 1 tab once daily; Atorvastatin 80 mg - 1 tab once daily; Levetiracetam - 1 tab twice daily; Metformin 500 mg - 1 tab once daily with breakfast; Hydralazine 50 mh - 1 tab twice da
none
unknown